UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevention of venous thromboembolism after neurosurgery

Thrombosis and haemostasis, 1999-08, Vol.82 (2), p.925-930

Agnelli, G

1999

Volltextzugriff (PDF)

Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement: The METHRO III study

Thrombosis and haemostasis, 2003-02, Vol.89 (2), p.288-296

2003

Volltextzugriff (PDF)

Venous thromboembolism and cancer: a two-way clinical association

Thrombosis and haemostasis, 1997-07, Vol.78 (1), p.117

Agnelli, G

1997

Volltextzugriff (PDF)

Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3)

Thrombosis and haemostasis, 2014-02, Vol.111 (2), p.213-225

2014

Volltextzugriff (PDF)

The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits

Thrombosis and haemostasis, 1990, Vol.63 (2), p.204-207

1990

Volltextzugriff (PDF)

End Points in Studies on the Prevention of Deep Vein Thrombosis

Seminars in thrombosis and hemostasis, 2001, Vol.27 (1), p.041-046

2001

Volltextzugriff (PDF)

A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture

Thrombosis and haemostasis, 1992-02, Vol.67 (2), p.203-208

1992

Volltextzugriff (PDF)

Randomised, double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers

Thrombosis and haemostasis, 2002-06, Vol.87 (6), p.947-952

2002

Volltextzugriff (PDF)

Choice of end-points in assessing the efficacy of post-discharge prophylaxis for venous thromboembolism

Thrombosis and haemostasis, 1998-01, Vol.79 (1), p.234-234

1998

Volltextzugriff (PDF)

Unresolved Issues in the Prevention and Treatment of Venous Thromboembolism

Seminars in thrombosis and hemostasis, 2002-06, Vol.28 (s2), p.033-040

Agnelli, Giancarlo

2002

Volltextzugriff (PDF)

Detection of asymptomatic deep vein thrombosis by real-time B-mode ultrasonography in hip surgery patients

Thrombosis and haemostasis, 1992-09, Vol.68 (3), p.257-260

1992

Volltextzugriff (PDF)

Clinical outcome of orthopaedic patients with negative lower limb venography at discharge

Thrombosis and haemostasis, 1995-10, Vol.74 (4), p.1042-1044

1995

Volltextzugriff (PDF)

Features of thrombi and diagnostic accuracy of impedance plethysmography in symptomatic and asymptomatic deep vein thrombosis

Thrombosis and haemostasis, 1993, Vol.70 (2), p.266-269

1993

Volltextzugriff (PDF)

Effects of standard heparin and a low molecular weight heparin (Kabi 2165) on fibrinolysis

Thrombosis and haemostasis, 1988, Vol.60 (2), p.311-313

1988

Volltextzugriff (PDF)

Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935)

Thrombosis and haemostasis, 1993, Vol.70 (2), p.294-300

1993

Volltextzugriff (PDF)

Effects of Hirudin and Heparin on the Binding of New Fibrin to the Thrombus in t-PA Treated Rabbits

Thrombosis and haemostasis, 1991, Vol.66 (5), p.592-597

1991

Volltextzugriff (PDF)

DDAVP induces systemic release of urokinase-type plasminogen activator

Thrombosis and haemostasis, 1989-09, Vol.62 (2), p.686-689

1989

Volltextzugriff (PDF)

Intramuscular dermatan sulfate MF701 in patients with hip fracture: relationship between pharmacokinetics and antithrombotic efficacy

Thrombosis and haemostasis, 1994-05, Vol.71 (5), p.553-557

1994

Volltextzugriff (PDF)

Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site

Thrombosis and haemostasis, 1993-05, Vol.69 (5), p.466-472

1993

Volltextzugriff (PDF)

The additive effect of low molecular weight heparins on thrombin inhibition by dermatan sulfate

Thrombosis and haemostasis, 1993-09, Vol.70 (3), p.443-447

1993

Volltextzugriff (PDF)

Plasma Thrombin Neutralization Assay: Pharmacokinetic Applications

Seminars in thrombosis and hemostasis, 1994-01, Vol.20 (3), p.266-273

1994

Volltextzugriff (PDF)

Dermatan Sulphate for the Prevention of Postoperative Venous Thromboembolism in Patients with Cancer

Thrombosis and haemostasis, 1999, Vol.82 (7), p.30-34

1999

Volltextzugriff (PDF)

Thrombolytic activity of two chimeric recombinant plasminogen activators (FK2tu-PA and K2tu-PA) in rabbits

Thrombosis and haemostasis, 1992, Vol.68 (3), p.331-335

1992

Volltextzugriff (PDF)

A hybrid plasminogen activator binds to the u-PA receptor and has a reduced thrombolytic potency in vivo

Thrombosis and haemostasis, 1993, Vol.69 (1), p.50-55

1993

Volltextzugriff (PDF)

Significantly lower need for blood transfusions associated with post-operatively initiated subcutaneous melagatran/oral ximelagatran compared with enoxaparin

Thrombosis and haemostasis, 2004, Vol.92 (2), p.428-430

2004

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Aktive Filter

KollektionThieme Connect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(8)

Publikationsform

Artikel
(46)

Sprache

Englisch
(46)

Erscheinungsjahr

n.n

Thema

Humans
(35)
Cardiovascular System & Cardiology
(33)
Hematology
(33)
Life Sciences & Biomedicine
(33)
Peripheral Vascular Disease
(33)
Science & Technology
(33)
Biological And Medical Sciences
(28)
Medical Sciences
(26)
Male
(20)
Female
(18)
Original Article
(17)
Pharmacology. Drug Treatments
(12)
Blood. Blood Coagulation. Reticuloendothelial System
(11)
Double-Blind Method
(11)
Middle Aged
(11)
Aged
(9)
Anticoagulants - Therapeutic Use
(8)
Animals
(7)
Phlebography
(7)
Rabbits
(7)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Prevention of venous thromboembolism after neurosurgery

Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement: The METHRO III study

Venous thromboembolism and cancer: a two-way clinical association

Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3)

The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits

End Points in Studies on the Prevention of Deep Vein Thrombosis

A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture

Randomised, double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers

Choice of end-points in assessing the efficacy of post-discharge prophylaxis for venous thromboembolism

Unresolved Issues in the Prevention and Treatment of Venous Thromboembolism

Detection of asymptomatic deep vein thrombosis by real-time B-mode ultrasonography in hip surgery patients

Clinical outcome of orthopaedic patients with negative lower limb venography at discharge

Features of thrombi and diagnostic accuracy of impedance plethysmography in symptomatic and asymptomatic deep vein thrombosis

Effects of standard heparin and a low molecular weight heparin (Kabi 2165) on fibrinolysis

Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935)

Effects of Hirudin and Heparin on the Binding of New Fibrin to the Thrombus in t-PA Treated Rabbits

DDAVP induces systemic release of urokinase-type plasminogen activator

Intramuscular dermatan sulfate MF701 in patients with hip fracture: relationship between pharmacokinetics and antithrombotic efficacy

Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site

The additive effect of low molecular weight heparins on thrombin inhibition by dermatan sulfate

Plasma Thrombin Neutralization Assay: Pharmacokinetic Applications

Dermatan Sulphate for the Prevention of Postoperative Venous Thromboembolism in Patients with Cancer

Thrombolytic activity of two chimeric recombinant plasminogen activators (FK2tu-PA and K2tu-PA) in rabbits

A hybrid plasminogen activator binds to the u-PA receptor and has a reduced thrombolytic potency in vivo

Significantly lower need for blood transfusions associated with post-operatively initiated subcutaneous melagatran/oral ximelagatran compared with enoxaparin

Aktive Filter

Suchergebnisse filtern